The breast cancer program features expert-led discussions on evolving evidence and real-world challenges in patient care. Explore the highlights and meet the co-chair leading this year’s conversations.

Agenda Highlights

March 14, 10:25 AM
Oral SERDs in Breast Cancer: They’re All the Same: Yes vs No
March 15, 10:25 AM
Should We Order ctDNA in the Adjuvant Setting for Early-Stage Breast Cancer Outside of Clinical Trials?: Yes vs No
March 15, 11:10 AM
All Patients With TNBC Should Receive Immune Checkpoint Inhibitor Therapy: Yes vs No
Back to top